Beyond Air (XAIR) Competitors $0.40 -0.01 (-3.12%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends XAIR vs. SRTS, ZJYL, TLSI, TELA, GUTS, FONR, ECOR, MGRM, EDAP, and LNSRShould you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include Sensus Healthcare (SRTS), Jin Medical International (ZJYL), TriSalus Life Sciences (TLSI), TELA Bio (TELA), Fractyl Health (GUTS), FONAR (FONR), electroCore (ECOR), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry. Beyond Air vs. Sensus Healthcare Jin Medical International TriSalus Life Sciences TELA Bio Fractyl Health FONAR electroCore Monogram Orthopaedics Edap Tms LENSAR Sensus Healthcare (NASDAQ:SRTS) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, community ranking, earnings, profitability, valuation and analyst recommendations. Which has higher valuation and earnings, SRTS or XAIR? Sensus Healthcare has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.31M2.82$490K$0.5712.46Beyond Air$2.34M12.42-$60.24M-$1.41-0.29 Which has more risk and volatility, SRTS or XAIR? Sensus Healthcare has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.23, meaning that its share price is 123% less volatile than the S&P 500. Is SRTS or XAIR more profitable? Sensus Healthcare has a net margin of 22.54% compared to Beyond Air's net margin of -2,369.17%. Sensus Healthcare's return on equity of 17.99% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare22.54% 17.99% 16.26% Beyond Air -2,369.17%-227.29%-106.51% Does the MarketBeat Community prefer SRTS or XAIR? Sensus Healthcare received 134 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 68.42% of users gave Sensus Healthcare an outperform vote. CompanyUnderperformOutperformSensus HealthcareOutperform Votes18268.42% Underperform Votes8431.58% Beyond AirOutperform Votes4869.57% Underperform Votes2130.43% Does the media favor SRTS or XAIR? In the previous week, Sensus Healthcare had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for Sensus Healthcare and 0 mentions for Beyond Air. Sensus Healthcare's average media sentiment score of 1.11 beat Beyond Air's score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the media. Company Overall Sentiment Sensus Healthcare Positive Beyond Air Neutral Do institutionals and insiders hold more shares of SRTS or XAIR? 25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 9.4% of Sensus Healthcare shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer SRTS or XAIR? Sensus Healthcare presently has a consensus price target of $12.50, indicating a potential upside of 76.06%. Beyond Air has a consensus price target of $3.67, indicating a potential upside of 809.62%. Given Beyond Air's higher probable upside, analysts plainly believe Beyond Air is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Beyond Air 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummarySensus Healthcare beats Beyond Air on 12 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Beyond Air News Delivered to You Automatically Sign up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAIR vs. The Competition Export to ExcelMetricBeyond AirSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.04M$4.36B$5.07B$9.08BDividend YieldN/A41.46%4.87%4.21%P/E Ratio-0.2925.0199.0517.15Price / Sales12.4245.671,121.17116.80Price / CashN/A43.4641.5237.88Price / Book0.547.364.754.78Net Income-$60.24M$13.64M$119.33M$225.60M7 Day Performance-13.31%-2.82%-1.86%-1.23%1 Month Performance-22.38%0.54%11.40%3.07%1 Year Performance-81.16%41.80%30.26%16.48% Beyond Air Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAIRBeyond Air4.1385 of 5 stars$0.40-3.1%$3.67+809.6%-78.9%$30.04M$2.34M-0.2970SRTSSensus Healthcare3.9859 of 5 stars$8.04-1.5%$12.50+55.5%+186.3%$131.78M$24.41M14.3240Positive NewsZJYLJin Medical InternationalN/A$0.79+1.5%N/A-99.0%$122.45M$19.82M0.00245Gap DownTLSITriSalus Life Sciences4.0096 of 5 stars$4.00+2.3%$12.08+202.1%-50.5%$121.97M$26.89M-1.57106Analyst ForecastInsider TradeNews CoverageGap UpTELATELA Bio2.9974 of 5 stars$2.85+2.9%$9.25+224.6%-49.8%$112.26M$58.45M-1.64120GUTSFractyl Health0.8814 of 5 stars$2.11+3.4%$22.00+942.7%N/A$101.49M$120,000.00-0.17102FONRFONAR1.0071 of 5 stars$15.46-0.5%N/A-25.8%$97.83M$102.01M11.09480ECORelectroCore2.6019 of 5 stars$14.39+5.7%N/A+164.2%$94.33M$23.33M-7.4450Analyst ForecastAnalyst RevisionNews CoverageMGRMMonogram Orthopaedics3.2379 of 5 stars$2.72+2.3%$4.00+47.1%-24.1%$93.33M$364,999.00-5.6628EDAPEdap Tms3.2811 of 5 stars$2.29+4.1%$19.00+729.7%-56.2%$84.97M$63.41M-3.38307LNSRLENSAR0.5658 of 5 stars$7.31-3.2%$8.00+9.4%+191.7%$84.91M$48.87M-5.17110News Coverage Related Companies and Tools Related Companies Sensus Healthcare Competitors Jin Medical International Competitors TriSalus Life Sciences Competitors TELA Bio Competitors Fractyl Health Competitors FONAR Competitors electroCore Competitors Monogram Orthopaedics Competitors Edap Tms Competitors LENSAR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XAIR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beyond Air With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.